| Model Number |
G57454 |
| Medical Device Problem Codes |
No Display/Image (1183); No Apparent Adverse Event (3189)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/17/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
As initially reported to customer relations via phone conversation with the district manager:
the device performed as it should.There was no issues with the device performance and the procedure went well.The physician wanted to report that during and undisclosed procedure the markers under fluoroscopy were very difficult to see.He in fact stated this as an in general feedback each time he uses the product.The physician brought it to the district managers attention as she was present during this procedure.Patient/event info - notes:
are images of the device or procedure available? yes.Did the patient have pre-existing conditions? yes
if yes, please specify:
morbid obesity, dvt.Please describe the native state of the vessel (i.E.Was the anatomy tortuous? was the vessel fibrotic?) n/a, tortuous, calcified, fibrotic, other
if other, please specify
acute dvt otherwise n/a.Was a stent previously placed during previous procedures? no.Was the device used percutaneously? yes.Where on the patient was the percutaneous access site? lesser saphenous vein.Was the access site jugular or femoral? other
if other, please specify:
lesser saphenous vein.What disease pathology was being treated? may thurner, acute or chronic obstruction, restenosis, other?
if other, please specify:
acute obstruction with underlying may thurner.Was the lesion approached via contralateral or ipsilateral? ipsilateral.Was pre-dilation performed ahead of placement of the stent? yes.What was the target location for the stent? left common iliac vein.Details of access sheath used (name, fr size, length)? 12fr, boston scientific, 11cm.Was the device flushed through both flushing ports before the procedure, as per ifu? yes.Details of the wire guide used (name, diameter, hyrdophyllic)? 260 amplatzz super stiff 0.035.Was post dilation performed after the placement of the stent? yes.Was the delivery system damaged/kinked/twisted during deployment? no.Were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? no
please specify if yes.
|
| |
|
Additional Manufacturer Narrative
|
|
Nio stent, iliac
product code: qan
pma/510(k) #: p200023
(b)(4)
investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
|
| |
|
Additional Manufacturer Narrative
|
|
Nio stent, iliac.Product code: qan.Pma/510(k) #: p200023.Device evaluation the zvt7-35-120-16-100 device of c1764342 lot number involved in this complaint was implanted in the patient and not available for evaluation.With the information provided, a document-based investigation was conducted.Document review prior to distribution all zvt7-35-120-16-100 devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for zvt7-35-120-16-100 of lot number c1764342 did not reveal any discrepancies that could have contributed to this complaint issue.Root cause review: a definitive root cause of user dissatisfaction was identified from the available information as the user felt that the markers were difficult to see under fluoroscopy.However, according to the customer testimony the device performed as it should, there were no issues with the device performance and the procedure went well.From the information available this complaint has been deemed as negative feedback.Summary: the complaint/negative feedback is confirmed based on customer testimony.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
|
| |
|
Event or Problem Description
|
|
Supplemental report being submitted due to the investigation being completed on 14-may-2021.As initially reported to customer relations via phone conversation with the district manager: the device performed as it should.There was no issues with the device performance and the procedure went well.The physician wanted to report that during and undisclosed procedure the markers under fluoroscopy were very difficult to see.He in fact stated this as an in general feedback each time he uses the product.The physician brought it to the district managers attention as she was present during this procedure.Patient/event info - notes: 1.Are images of the device or procedure available? yes.2.Did the patient have pre-existing conditions? yes.If yes, please specify: morbid obesity, dvt.3.Please describe the native state of the vessel (i.E.Was the anatomy tortuous? was the vessel fibrotic?) n/a, tortuous, calcified, fibrotic, other if other, please specify.Acute dvt otherwise n/a.4.Was a stent previously placed during previous procedures? no.5.Was the device used percutaneously? yes.6.Where on the patient was the percutaneous access site? lesser saphenous vein.7.Was the access site jugular or femoral? other.If other, please specify: lesser saphenous vein.8.What disease pathology was being treated? may thurner, acute or chronic obstruction, restenosis, other? if other, please specify: acute obstruction with underlying may thurner.9.Was the lesion approached via contralateral or ipsilateral? ipsilateral 10.Was pre-dilation performed ahead of placement of the stent? yes.11.What was the target location for the stent? left common iliac vein.12.Details of access sheath used (name, fr size, length)? 12fr, boston scientific, 11cm.13.Was the device flushed through both flushing ports before the procedure, as per ifu? yes.14.Details of the wire guide used (name, diameter, hyrdophyllic)? 260 amplatzz super stiff 0.035.15.Was post dilation performed after the placement of the stent? yes.16.Was the delivery system damaged/kinked/twisted during deployment? no.17.Were any other defects (other than the complaint issue) observed on the delivery system prior to return (e.G.Kink)? no.Please specify if yes.
|
| |
|
Search Alerts/Recalls
|
|